David A. Liebner
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 25
- Oncology 28
- CAR-T cell therapy research 11
- Vascular Tumors and Angiosarcomas 11
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Manisha H. Shah (2 shared papers)Kun Huang (1 shared paper)Jeffrey D. Parvin (1 shared paper)Ling Bian (1 shared paper)James L. Chen (11 shared papers)Brian Andrew Van Tine (8 shared papers)Amit Agrawal (1 shared paper)Fadi Nabhan (1 shared paper)
- Journals
- Journal of Clinical Oncology (18 papers)Journal of Surgical Oncology (4 papers)Journal of the National Comprehensive Cancer Network (3 papers)Annals of Oncology (3 papers)Cancers (2 papers)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
David A. Liebner
55 papers receiving 787 citations
Peers
Comparison fields: 5 of 73
- Oncology 358
- Pulmonary and Respiratory Medicine 291
- Cancer Research 90
- Immunology 93
- Pathology and Forensic Medicine 66
Countries citing papers authored by David A. Liebner
This map shows the geographic impact of David A. Liebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Liebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Liebner more than expected).
Fields of papers citing papers by David A. Liebner
This network shows the impact of papers produced by David A. Liebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Liebner. The network helps show where David A. Liebner may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Liebner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 55 | |
| 2 | 2015 | 55 | |
| 3 | 2016 | 49 | |
| 4 | 2017 | 42 | |
| 5 | 2011 | 41 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 40 | |
| 8 | 2007 | 32 | |
| 9 | 2015 | 29 | |
| 10 | 2018 | 28 | |
| 11 | 2015 | 27 | |
| 12 | 2014 | 27 | |
| 13 | 2019 | 25 | |
| 14 | 2016 | 24 | |
| 15 | 2019 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2022 | 15 | |
| 18 | 2022 | 14 | |
| 19 | 2020 | 14 | |
| 20 | 2006 | 14 |
About David A. Liebner
David A. Liebner is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Pathology and Forensic Medicine and Rheumatology, having authored 61 papers that have together received 801 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (25 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (11 papers), Vascular Tumors and Angiosarcomas (11 papers), Cancer Immunotherapy and Biomarkers (6 papers), Soft tissue tumor case studies (5 papers), Wildlife Ecology and Conservation (4 papers) and Cardiac tumors and thrombi (4 papers). The work is most often cited by research in Oncology (358 citations), Pulmonary and Respiratory Medicine (291 citations), Cancer Research (90 citations), Immunology (93 citations) and Pathology and Forensic Medicine (66 citations). David A. Liebner has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Manisha H. Shah, Kun Huang, Jeffrey D. Parvin, Ling Bian, James L. Chen, Brian Andrew Van Tine, Amit Agrawal, Fadi Nabhan, Amy Joehlin‐Price and Sandra P. D’Angelo. Their work appears in journals such as Journal of Clinical Oncology, Journal of Surgical Oncology, Journal of the National Comprehensive Cancer Network, Annals of Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.